Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 4,976 shares at $45.01 ($224K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Scheduled sale ($224k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 2,340 | $105K | 47.0% |
| 2 | $45.01 | 2,340 | $105K | 47.0% |
| 3 | $46.00 | 296 | $14K | 6.1% |
| Total | $45.07 avg | 4,976 | $224K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |